The M-OVIN study: does switching treatment to FSH and / or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate – a randomised controlled trial

BACKGROUND: Clomiphene citrate (CC) is first line treatment in women with World Health Organization (WHO) type II anovulation and polycystic ovary syndrome (PCOS). Whereas 60% to 85% of these women will ovulate on CC, only about one half will have conceived after six cycles. If women do not conceive...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Nahuis, Marleen J, Weiss, Nienke S, van der Veen, Fulco, Mol, Ben Willem J, Hompes, Peter G, Oosterhuis, Jur, Lambalk, Nils B, Smeenk, Jesper MJ, Koks, Carolien AM, van Golde, Ron JT, Laven, Joop SE, Cohlen, Ben J, Fleischer, Kathrin, Goverde, Angelique J, Gerards, Marie H, Klijn, Nicole F, Nekrui, Lizka CM, van Rooij, Ilse AJ, Hoozemans, Diederik A, van Wely, Madelon
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2013
Onderwerpen:
Study Protocol
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3828011/
https://ncbi.nlm.nih.gov/pubmed/24160333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6874-13-42
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items